- Home
- GHRS
GHRS
GH Research PLC
as 10-03-2025 4:00pm EST
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
| Founded: | 2018 | Country: | Ireland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 774.1M | IPO Year: | 2021 |
| Target Price: | $30.63 | AVG Volume (30 days): | 307.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.73 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.00 - $20.50 | Next Earning Date: | 11-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest GH Research PLC News
GHRS Breaking Stock News: Dive into GHRS Ticker-Specific Updates for Smart Investing
Yahoo Finance
15 days ago
Saylor crypto imitators are now under pressure as doubts grow about their business model
Yahoo Finance Video
15 days ago
Trump weighs declaring housing emergency: What the admin. can do
CBS News
15 days ago
3 reasons your grocery bill is getting more expensive
USA TODAY
15 days ago
Disaster preparation has a new wildcard. Will FEMA help?
Reuters
15 days ago
'Canada will take a close look at the Teck-Anglo deal,' finance minister says
Insider Monkey
15 days ago
BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets
Insider Monkey
15 days ago
GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity
Insider Monkey
15 days ago
American Healthcare REIT Strengthens Growth Outlook with Q2 Gains and Expansion Plans
Compare GHRS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GHRS GH Research PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.